CFO departs Intercept as trickle becomes mass exodus from NASH biotech
Intercept’s leadership has now been almost entirely hollowed out and turned over. On Wednesday, the once highly-valued biotech announced that its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
